glp 1 pseudotumor cerebri Impact of GLP-1 receptor agonists on idiopathic intracranial hypertension clinical and neurosurgical outcomes: a propensity-matched multi-institutional cohort study in: Journal of Neurosurgery Volume 143 Issue 4 (2025) Journals Recurrent Idiopathic Intracranial Hypertension–Related Papilledema

Our Physicians are properly trained and highly experienced

Orlistat reduces fat absorption but can cause digestive side effects, while SGLT2 inhibitors, used in type 2 diabetes, tend to produce only modest weight loss while helping protect the heart and kidneys

Hypoxia-inducible factor-1alpha-dependent induction of miR122 enhances hepatic ischemia tolerance

The STEP program trials with semaglutide (a GLP-1-only agonist) and the SURMOUNT trials with tirzepatide (dual GIP/GLP-1 agonist) represent the strongest weight loss efficacy data in the history of pharmacotherapy for obesity

They are the holy grail of modern medicine." Dr